Upper management has been grasping at straws trying to keep this division afloat for the last few years. Lots of outdated managers and old timer reps hanging on for dear life. All the while the company slowly backfills positions with entry level reps from enterprise rent-a-car.
Doesn’t take an advance degree in economics to forecast how much GSK will save by slashing this division and investing elsewhere in the company. Half the Trelegy sales force is already outsourced to Syneos. Like it’s been said before, do the math.